Results 221 to 230 of about 47,798 (276)
Some of the next articles are maybe not open access.

Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges.

Journal of Magnetic Resonance Imaging, 2019
Historically, breast magnetic resonance imaging (MRI) was not considered an effective modality in the evaluation of ductal carcinoma in situ (DCIS). Over the past decade this has changed, with studies demonstrating that MRI is the most sensitive imaging ...
Heather I. Greenwood   +3 more
semanticscholar   +1 more source

Pro: SLNB in DCIS

Annals of Surgical Oncology, 2006
The role of sentinel node mapping and biopsy in the management of ductal carcinoma in situ (DCIS) remains controversial. A debate about the use of a staging technique for the evaluation of a malignancy without metastatic potential seems absurd. However, this debate is fueled by two factors. First, some patients diagnosed with DCIS will ultimately prove
openaire   +2 more sources

Experiences with DCI Pattern

2015
The DCI architectural pattern for software, introduced by Reenskaug, contains three parts: Data, Context and Interaction. Data represent domain knowledge while Context and Interaction represent the business logic by implementing communication between objects. Context dynamically injects roles into objects.
Ilona Bluemke, Anna Stepien
openaire   +1 more source

Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.

Academic Radiology, 2019
RATIONALE AND OBJECTIVES To determine the upgrade rate of magnetic resonance imaging (MRI)-detected ductal carcinoma in situ (DCIS) and to identify patient, imaging, and pathologic features that may predict the risk of upgrade.
L. Lamb   +3 more
semanticscholar   +1 more source

Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component

Annals of Surgical Oncology, 2010
Breast ductal carcinoma in situ with microinvasion (DCIS-Mi) is considered to be the interim stage in the progression from DCIS to invasive breast cancer (IDC). Cases that exceed DCIS-Mi but still do not fulfill the diagnostic criteria of IDC often are observed.
Ke-Da, Yu   +6 more
openaire   +2 more sources

Is DCIS Overrated?

2018
Ductal carcinoma in situ (DCIS), the noninvasive form of breast cancer (BC), comprises just over 20% of breast cancer cases diagnosed each year in the USA. Most patients are treated with local excision of the disease followed by whole breast radiation therapy.
Joshua, Feinberg   +3 more
openaire   +2 more sources

The Impact of MRI on the Treatment of DCIS

The American Surgeon™, 2005
Magnetic resonance imaging (MRI) has been shown to detect occult invasive breast cancers with a sensitivity of 97 per cent to 100 per cent. Mammography and ultrasonography does not accurately assess the extent of ductal carcinoma in situ (DCIS), which results in a high reoperation rate.
Alice, Chung   +3 more
openaire   +2 more sources

Zbrinjavanje DCIS

2023
U predavanju je obuhvaćeno povijesno i sadašnje zbrinjavanje duktalnog karcinoma in situ, prikazani su rezultati Klinike za tumore u liječenju DCIS, uključujući učestalost recidiva nakon 10-15 godina. Također, prikazani su trendovi budućeg liječenja ove bolesti, kao i prospektivne studije koje su u tijeku, a istražuju aktivno praćenje DCIS ...
Stanec, Mladen   +2 more
openaire  

The defence for the U.K. DCIS trial

European Journal of Cancer, 1993
INTRODUCTION THE U.K. ductal carcinoma in siru (DCIS) trial started in May 1991, after a gestation period of 36 months, having been designed by a multidisciplinary committee. This comprised clinicians with a particular interest in DCIS and included surgeons, radiotherapists, pathologists, statisticians and data centre coordinators. The aim of the study
I S, Fentiman, C A, Joslin
openaire   +2 more sources

Current management of DCIS: a review

Breast Cancer Research and Treatment, 2007
Ductal carcinoma in-situ (DCIS) is a heterogeneous disease, in terms of its radiological characteristics, histological morphology and molecular attributes. This diversity is reflected in its natural history and influences optimal treatment strategy. A significant proportion of DCIS lesions behave in a clinically benign fashion and do not progress to ...
Neill, Patani   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy